Drug Shortage Report for EPIPEN
Report ID | 20797 |
Drug Identification Number | 00509558 |
Brand name | EPIPEN |
Common or Proper name | EPIPEN |
Company Name | MYLAN SPECIALTY LP |
Market Status | MARKETED |
Active Ingredient(s) | EPINEPHRINE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | Each (0.3MG/0.3ML AUTO-INJECTOR) |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-09-27 |
Actual start date | |
Estimated end date | |
Actual end date | 2017-10-06 |
Shortage status | Resolved |
Updated date | 2017-10-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3711 COLLINS FERRY ROAD MORGANTOWN, WEST VIRGINIA UNITED STATES 26505 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-09-01 | English | Compare |
v2 | 2017-09-01 | French | Compare |
v3 | 2017-09-14 | English | Compare |
v4 | 2017-09-14 | French | Compare |
v5 | 2017-09-28 | English | Compare |
v6 | 2017-10-10 | English | Compare |
v7 | 2017-10-10 | English | Compare |
v8 | 2017-10-10 | French | Compare |
Showing 1 to 8 of 8